Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

7.28
Delayed Data
As of 3:59pm ET
 +0.20 / +2.82%
Today’s Change
5.02
Today|||52-Week Range
13.26
-7.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues48.9M47.8M102.8M89.3M
 
 
 
 
 
Cost of Goods Sold------46.0K
 
 
Depreciation And Amortization3.7M2.6M3.2M4.3M
 
 
 
 
 
 
Operating ExpensesGross Income------84.9M
 
 
General Expenses138.0M164.9M165.8M214.5M
 
 
 
 
 
Research And Development125.9M146.3M138.5M161.0M
 
 
 
 
 
Total Operating Expenses141.7M167.5M169.0M218.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-92.7M-119.7M-66.3M-129.6M
 
 
 
 
 
Extraordinary Charge0.00-800.0K0.000.00
 
 
Interest Expense On Debt553.0K10.9M18.2M19.2M
 
 
 
 
 
Other Expenses1.4M627.0K813.0K917.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-91.8M-130.7M-83.6M-147.8M
 
 
 
 
 
Minority Interest-477.0K-240.0K-268.0K-170.0K
 
 
 
 
 
Net Income-91.3M-130.9M-83.3M-148.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.8M98.9M104.4M111.4M
 
 
 
 
 
Shares To Calculate EPS Diluted72.8M98.9M104.4M111.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.28-$1.32-$0.80-$1.33
 
 
 
 
 
EPS Diluted-$1.25-$1.32-$0.80-$1.33